Open-label adjunctive zonisamide in the treatment of bipolar disorders: A prospective trial

Journal of Clinical Psychiatry

Volumn 66, Issue 5, 2005, Pages 617-624

  McElroy, Susan L ^a   Suppes, Trisha ^b   Keck Jr , Paul E ^a   Black, David ^c   Frye, Mark A ^c   Altshuler, Lori L ^c   Nolen, Willem A ^d   Kupka, Ralph W ^e   Leverich, Gabriele S ^f   Walden, Jorg ^g   Grunze, Heinz ^h   Post, Robert M ^f  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Altrecht Institute for Mental Health Care   (Netherlands)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^g UNIVERSITY OF FREIBURG   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM CARBONATE; MOOD STABILIZER; OLANZAPINE; PHENYTOIN; PSYCHOTROPIC AGENT; RISPERIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; ZONISAMIDE;

ADJUVANT THERAPY; ADULT; ARTICLE; BIPOLAR DISORDER; BODY MASS; BODY WEIGHT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DEPRESSION; DIARRHEA; DRUG EFFICACY; FATIGUE; FEMALE; GAIT DISORDER; HUMAN; INVENTORY FOR DEPRESSIVE SYMPTOMATOLOGY; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; MOOD; NAUSEA; OPEN STUDY; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SEDATION; SIDE EFFECT; THIRST; TREATMENT OUTCOME; TREMOR; WEIGHT REDUCTION; XEROSTOMIA; YOUNG MANIA RATING SCALE;

EID: 21144439005     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0512     Document Type: Article

References (39)

1. Oommen KJ, Mathew SS. Zonegran: a new antiepileptic drug. Clin Neuropharmacol 1999;22:192-200
2. Leppik IE. Zonegran: a novel antiepileptic agent. Today's Therapeutic Trends 1999;17:181-195
3. Faught E, Ayala R, Montouris GG, et al. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-1779
4. Seino M, Fujitani B. Zonisamide: clinical efficacy and use in epilepsy. In: Levy RH, Mattson RH, Meldrum BS, et al, eds. Antiepileptic Drugs. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:885-891
5. Rho JM, Sankar R. The pharmacologic basis of antiepileptic drug action. Epilepsia 1999;40:1471-1483
6. Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995;22:193-205
7. Okada M, Hirano T, Kawata Y, et al. Biphasic effects of zonisamide on serotonergic system in rat hippocampus. Epilepsy Res 1999;34:187-197
8. +, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode. Br J Pharmacol 1998;124: 1277-1285
9. MacDonald RL. Zonisamide: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, et al, eds. Antiepileptic Drugs. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:867-872
10. Wang PW, Ketter TA, Becker OV, et al. New anticonvulsant medication uses in bipolar disorder. CNS Spectr 2003;8:930-932, 941-947
11. Keck PE Jr, McElroy SL. Treatment of bipolar disorder. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. 3rd ed. Washington, DC: American Psychiatric Press Publishing; 2003
12. Mishory A, Yaroslavsky Y, Bersudsky Y, et al. Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 2000;157:463-465
13. Weisler RH, Kalali AH, Ketter TA, and the SPD417 Study Group. A multicenter, randomized, double-blind, placebo-controlled trial of extended release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65:478-484
14. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88
15. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400
16. Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance therapy in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-1024
17. Kanba S, Yagi G, Kamijima K, et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:707-715
18. Berigan TR. Zonisamide treatment of bipolar disorder: a case report [letter]. Can J Psychiatry 2002;47:887
19. Baldassano CF, Lipari MA, Ghaemi SN, et al. Adjunctive zonisamide as acute treatment of bipolar disorder outpatients [abstract]. Presented at the annual meeting of the American Epilepsy Society; December 6-11, 2002; Seattle, Wash
20. Post RM, Weiss SRB, Clark M, et al. Lithium, carbamazepine, and valproate in affective illness. In: Manji HK, Bowden CL, Belmaker RH, eds. Bipolar Medications Mechanisms of Action. Washington, DC: American Psychiatric Press; 2000:219-248
21. Gadde KM, Francisy DM, Wagner R. Zonisamide in obesity. JAMA 2003;289:1820-1825
22. McElroy SL, Kotwal R, Hudson JI, et al. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. J Clin Psychiatry 2004;65:50-56
23. Elmslie JL, Silverstone JT, Mann JL, et al. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000;61:179-184
24. McElroy SL, Frye MA, Suppes T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002; 63:207-213
25. Fagiolini A, Frank E, Houck E, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002;63:528-533
26. Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003; 160:112-117
27. Keck PE Jr, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 2003;64:1426-1435
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
29. Leverich GS, Nolen WA, Rush AJ, et al. The Stanley Foundation Bipolar Treatment Outcome Network, 1: longitudinal methodology. J Affect Disord 2001;67:33-44
30. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (Research Version, 2/96 Final). New York, NY: Biometrics Research, New York State Psychiatric Institute, 1996
31. Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997;73:159-171
32. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435
33. Rush AJ, Giles DE, Schlesser MA, et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1985;18: 65-87
34. Mather GC, Shah J. Zonisamide: drug interactions. In: Levy RH, Mattson RH, Meldrum BS, et al, eds. Antiepileptic Drugs. 5th ed. Philadelphia, Pa: Lippincott Williams & Williams; 2002:880-884
35. Shah J, Shellenberger K, Canafax DM. Zonisamide: chemistry, biotransformation, and pharmacokinetics. In: Levy RH, Mattson RH, Meldrum BS, et al, eds. Antiepileptic Drugs. 5th ed. Philadelphia, Pa: Lippincott Williams & Williams; 2002:873-879
36. Abraham G, Owen J. Topiramate can cause lithium toxicity [letter]. J Clin Psychopharmacol 2004;24:565-567
37. Charles C, Stoez L, Tollefson G. Zonegran-induced mania. Psychosomatics 1990;31:214-221
38. Kimura S. Zonegran-induced behavior disorder in two children. Epilepsia 1994;35:403-405
39. Ozaawa K, Kobayashi K, Noda S, et al. Zonisamide-induced depression and mania in patients with epilepsy [letter]. J Clin Psychopharmacol 2004;24:110-111